相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
J. Kuhle et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Assessment of Disease Activity in Multiple Sclerosis Phenotypes with Combined Gadolinium- and Superparamagnetic Iron Oxide-enhanced MR Imaging
Thomas Tourdias et al.
RADIOLOGY (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study
Marco Rovaris et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Neurofilament light as a prognostic marker in multiple sclerosis
Jonatan Salzer et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Astrocytic damage is far more severe than demyelination in NMO A clinical CSF biomarker study
R. Takano et al.
NEUROLOGY (2010)
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer et al.
BRAIN (2009)
Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis
C. E. Teunissen et al.
NEUROLOGY (2009)
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis
L. K. Fisniku et al.
BRAIN (2008)
Glial and Axonal Body Fluid Biomarkers Are Related to Infarct Volume, Severity, and Outcome
Axel Petzold et al.
Journal of Stroke & Cerebrovascular Diseases (2008)
CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus
A. Agren-Wilsson et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
Neurofilament and glial fibrillary acidic protein in multiple sclerosis
N Norgren et al.
NEUROLOGY (2004)
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS
C Malmeström et al.
NEUROLOGY (2003)
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process
C Confavreux et al.
BRAIN (2003)
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
A Petzold et al.
BRAIN (2002)
Heightened intrathecal release of axonal cytoskeletal proteins in multiple sclerosis is associated with progressive disease and clinical disability
YK Semra et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000)
LF Eng et al.
NEUROCHEMICAL RESEARCH (2000)
Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
JS Alpert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
